News
RARE ▲ +2.1% - Ultragenyx Pharmaceutical Inc.
RARE ▲ +2.1% - Ultragenyx Pharmaceutical Inc.
$RARE - Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
14-OCT-2026 08:30 AM ET
Share this post
More filings for $RARE
RARE ▲ +12.2% - Ultragenyx Pharmaceutical Inc.Sep 17, 2026RARE ▼ -42.8% - Ultragenyx Pharmaceutical Inc.Sep 2, 2026RARE ▼ -41.8% - Ultragenyx Pharmaceutical Inc.Sep 2, 2026RARE ▲ +2.0% - Ultragenyx Pharmaceutical Inc.Sep 1, 2026RARE - Ultragenyx Pharmaceutical Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026RARE - Ultragenyx Pharmaceutical Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $RARE filing history →💬 Comments
Loading comments…
Leave a comment